Digital health news, funding round up in the prior week; May 15, 2023

Amino Health raised $80M; ŌURA acquired Proxy; Babylon Health went private

Top Health News

• Sunrise, which allows for diagnosis of obstructive sleep apnea (OSA) from home through the use of artificial intelligence-powered technology, announced a partnership with with Signifier Medical Technologies, a medtech company focused on the development and commercialisation of solutions for patients with snoring and sleep-disordered breathing conditions. This collaboration will involve combining Sunrise's AI solution with eXciteOSA, a device that delivers targeted Neuromuscular Electrical Stimulation (NMES) to help people breathe better, even when they are awake, as well as Signifier Medical’s patient management portal, allowing healthcare providers to gather data on their patients, and provide them with tools so they can understand each patient's unique needs.
• Lifesum, a a nutrition platform that wants to democratize healthy eating by empowering people with tools to understand their personal nutritional needs, added a sleep tracking feature to its platform  via a partnership with ŌURA, the company behind the Oura Ring, a device that gives users personalized health data, insights, and daily guidance. Partnering with ŌURA enables Lifesum users to track sleep across data points including duration and quality, and receive personalized sleep insights and actionable feedback to improve their eating habits and reach their health goals, Falk explained. The feature will also builds on Lifesum's integration of Health Connect by Android, which allows health and fitness apps to easily manage shared data in one place. With Health Connect for Android, Lifesum users will be able to access their sleep data from ŌURA and get actionable insights related to how they eat and sleep.
• Google announced that it is expanding the beta version of its Health Connect app, an Android platform that allows for data sharing between health and fitness apps to Japan. It selected six launch partners in the country, including Ubie, developer of an AI-based symptom tracking platform that help guide the patient to the correct treatment option, as well as an AI-powered patient intake product that allows physicians to know what the problem is they're treating before they ever see the patient. By linking Health Connect (Beta) and their Ubie AI Symptom Checker, users can gain access to health-related data from other apps that can improve the accuracy of their symptom-related questionnaires.
• HealthJoy, a benefits navigation platform that amplifies employer benefit strategies to contain healthcare costs and helps members lead healthier lives, announced an expanded partnership with Teladoc Health, a provider of whole-person virtual care, to introduce virtual primary care. HealthJoy Virtual Primary Care, powered by Teladoc Health, provides a fully integrated primary care experience that supports members throughout their entire healthcare journey. The solution will further enhance HealthJoy's comprehensive suite of virtual care offerings that already includes adult and adolescent mental health, chronic care management, dermatology, employee assistance program services, musculoskeletal therapy, nutrition, tobacco cessation, and urgent care. By creating a seamless, fully integrated, navigable healthcare experience, HealthJoy is removing the barriers that have historically prevented employees from accessing high-quality, affordable care.
• CVS Health announced it is enhancing Project Health, the company's free, community-based health screening program by adding mental health screenings to its services and entering two new areas: Greensboro, NC and Petersburg, VA. Project Health will also add nearly 100 organizations this year to host its mobile units in additional under-resourced communities. CVS Health plans to host nearly 2,000 Project Health screening events across the U.S. in 2023. The company hosts these events at CVS Pharmacy locations and community organizations, offering free biometric screenings including blood pressure, cholesterol, glucose level and body mass index to detect early risks of chronic conditions such as diabetes, hypertension and heart disease. The screenings will now also offer PHQ-2 assessments, screenings to help identify people who require additional evaluation for depression. Following these screenings, participants have the opportunity to meet with a nurse practitioner who can provide referrals for treatment and advice on follow-up care.
• Doceree, a platform building unprecedented solutions for healthcare professionals through programmatic messaging with proprietary data tools, announced its long-term partnership with Hello Health Group. The collaboration is expected to accelerate growth for both companies by combining the world-class HCP targeting and reach capabilities of Doceree with Hello Health's leading patient and consumer reach and engagement solutions, and its strong geographical presence in the South East Asian region. The partnership further strengthens Doceree's global footprint by giving it access to eight key markets – Vietnam, Indonesia, Malaysia, Cambodia, Myanmar, Singapore, Philippines and Taiwan.
• Advisers for the US Food and Drug Administration voted unanimously in support of making the birth-control pill Opill available over-the-counter, saying the benefits outweigh the risks. Two FDA advisory panels agreed that people would use Opill safely and effectively and said groups such as adolescents and those with limited literacy would be able to take the pill at the same time every day without help from a health care worker. The advisers were asked to vote on whether people were likely to use the tablet properly so that the benefits would exceed the risks. Seventeen voted yes. Zero voted no or abstained.
• Revvity officially launched as a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives everywhere. Born from two words, “revolutionize” (rev) and “vita” (vit) meaning “life” in Latin, Revvity delivers end-to-end expertise and solutions from research discovery to development, and diagnosis to cure. The Company was previously affiliated with PerkinElmer.
• NextGen Healthcare, a provider of innovative, cloud-based healthcare technology solutions, announced that CHE Behavioral Health Services has chosen NextGen Behavioral Health Suite to support its growing network. CHE Behavioral Health, based in Carlsbad, Calif., is a multispecialty, clinic-based group comprising 900+ licensed professionals dedicated to increasing access to mental health services. CHE is licensed to provide services in 47 states across the U.S. and will initially begin using NextGen Behavioral Health Suite in 14 states. NextGen Behavioral Health Suite is a comprehensive solution that gives providers access to a single, integrated physical and behavioral health record to treat the whole patient.
• Ginkgo Bioworks, which is building a platform for cell programming and biosecurity, announced a new partnership with Boehringer Ingelheim. The two companies will leverage Ginkgo's natural product discovery capabilities to accelerate the discovery and development of novel therapeutic molecules to address diseases with high unmet patient needs that are out of reach of conventional drug discovery.
• Emory Healthcare and the Goizueta Institute @Emory Brain Health are joining forces with NeuroFlow, a behavioral health infrastructure company, to support and improve the delivery of psychiatric services for both patients and providers. The collaboration will also pilot a primary care suicide prevention program. The entities will seek to complement and scale Emory’s new collaborative care model within its primary care clinics. The CoCM is part of Emory’s Integrated Behavioral Health Program, which was formed by the Department of Psychiatry and Behavioral Sciences to help meet significant access demands for behavioral health services in the EHC network.
• Babylon Health, a digital primary care provider, announced plans to be taken private as it continues to be saddled with mounting losses. The company entered into a funding agreement with AlbaCore Capital LLP that will provide up to $34.5 million in interim funding to provide liquidity to support Babylon’s ongoing operations. As part of a longer-term plan, which includes restructuring the company's debt, the agreement will support Babylon's plans to be taken private.
• athenahealth, a provider of network-enabled software and services for medical groups and health systems nationwide, announced that Community Health Access Network – a Health Center Controlled Network located in Newmarket, New Hampshire – is implementing athenaOne in seven Federally Qualified Health Centers to help strengthen care delivery and improve health outcomes for their patients. CHAN delivers technology, training, and technical assistance to support approximately 250 providers who deliver care to communities in New Hampshire, Texas, and Vermont. After an extensive evaluation process, CHAN turned to athenahealth for critical functionality that the FQHCs need to better engage patients, streamline operations, and enable data-driven decision making.
• Health In Tech, an insurtech company that delivers disruptive innovation and reimagines self-funded health plans, partnered with ClaimsBridge as its network management firm. This collaboration aims to equip brokers with an enhanced set of tools and resources, enabling them to manage their client's employee benefits more effectively and control healthcare costs efficiently. ClaimsBridge will provide Health In Tech with a complete portfolio of network solutions, including high-performance networks, direct contracts, and regional provider networks, all powered by ClaimsBridge's unique proprietary Connect platform, which streamlines implementation and claim flow.
• Humana announced that it reached agreement with two national organizations to provide Durable Medical Equipment services to help Humana Medicare Advantage HMO members achieve their best health at home. The national DME providers, AdaptHealth Corp. and Rotech Healthcare Inc., will begin providing DME services for Humana’s Medicare Advantage HMO enrollees under a value-based structure beginning July 1, with each serving a specific region of the country.
• Drexi, a pharmacy benefit manager, announced a new partnership with Levrx Technology Inc, a digital health technology company that drives prescription efficiencies and maximizes savings. Powered by the digital Levrx platform, Drexi members will have the ability to seek out lowest prescription prices and make more informed decisions about their healthcare. The Levrx platform equips Drexi members with access to information on the pharmacy that offers their specific prescription at the lowest cost, closest to them. Additionally, members can request a switch to lower cost medications or pharmacy locations with just a click. This partnership will allow Drexi to focus on cost savings for its members while navigating the complex pharmacy space and still provide significant savings back to its plans.
• Oscar Health will exit the Covered California marketplace at the end of this year after failing to meet performance metrics in the state, executives announced during its first-quarter earnings call Tuesday. The insurer plans to exit the state — where it said it had expected to have 35,000 members at the end of this year— after consistently recording medical loss ratios over 100%, executives said. Newly appointed CEO Mark Bertolini said on the call that Oscar would “pause” implementation in California with the intention of reentering the state in the future after reshaping its product offerings and strategy.
• Enhance Health, a technology-enabled, digital health insurance brokerage and care navigation platform, finalized an agreement as an official partner of the Miami Dolphins and Hard Rock Stadium in Miami Gardens, Fla. The multi-year partnership provides wide-spread visibility for the insurance organization between two offices in the Fort Lauderdale area.
• Abbott announced a series of new programs within its multi-million-dollar initiative to increase diversity in clinical trials and improve care among under-represented populations. The new additions to Abbott's Diversity in Clinical Trials initiative build on the partnerships, scholarships, and the focus on diversified participants in the company's own clinical trials during the initiative's first year. The latest programs include the launch of a new initiative with the Norton Healthcare Foundation to build and implement new models of sustainable clinical research alongside the Institute for Health Equity, a Part of Norton Healthcare in Louisville, Ky.; a new training program for clinical research coordinators in partnership with Barnett International; and a newly-created Diversity in Research Office at Abbott focused on ensuring diverse representation in clinical trials.
• Babson College and Uwill, a teletherapy solution for colleges and students, announced a partnership to complement the college's existing counseling capabilities, and provide students additional mental health resources. As the mental health crisis continues to grow around higher education, Babson adds Uwill's proprietary technology to facilitate immediate appointments with licensed mental health counselors based on student needs. In addition, it directly connects students in crisis with licensed counselors trained in trauma to assess student risk, deescalate situations, and offer as-needed response.
• Health Catalyst, a provider of data and analytics technology and services to healthcare organizations, announced a multi-year partnership with Sea Mar Community Health Centers, a provider of health and social services delivering high quality, integrated care for underserved communities. To gain greater visibility into patient data, increased insight into its patient population, and improved reporting capabilities, Sea Mar will implement Health Catalyst's data platform, Health Catalyst Pop Analyzer, Health Catalyst Pop Insights, and Self-Service Analytics. Leveraging Health Catalyst's software and Professional Services, Sea Mar will be empowered to make proactive, data-driven decisions.
• Roche UK and digital health technology company Nye Health announced a partnership aiming to co-create digital solutions that learn, personalise and adapt to patients’ needs outside of a hospital or traditional clinical setting. Co-created with patients, the tools will have the potential to identify new digital biomarkers and disease trajectories. The partnership will first focus on the development of digital tools to improve pharmacovigilance in a post-market authorisation context.
• XTM, a Fintech creator of payment innovations and mobile solutions specifically for service industries including hospitality, personal care and service staff. announced a partner agreement with Virtual Health Care Provider CloudMD Software & Services Inc. enabling them to offer on-demand health care and mental health support to their 200,000 Today Program members.
• SelectQuote, a distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, announced that Wellcare, the Medicare brand of Centene Corporation, named SelectQuote a Preferred Medicare Sales and Distribution Partner.
• BayCare Health System and healthPrecision announced a strategic partnership to bring advanced documentation tools to the hospital bedside to improve accuracy, efficiency, nurse satisfaction and patient outcomes. The co-development of healthPrecision's Medical Brain artificial intelligence platform at BayCare will be the first time the technology has been applied to help reduce hospital nurses' documentation burden, allowing them to focus on what matters most — caring for patients. Documentation, while essential to high-quality patient care, can consume a significant part of nurses' daily duties and can add to their stress on the job.
• Delve Health, a virtual health and technology firm, and cerascreen, an at-home health diagnostic testing company, announced a partnership to expand access to digital healthcare solutions worldwide via smart and wearable devices (e.g., smart phones, tablets, wrist wearables, etc.). Delve Health provides a fully-customizable mobile and web-based platform that enables cerascreen consumers the opportunity to monitor and track their health data—supporting and empowering people to take a more active role in their own healthcare journey.
• Upswing Health, a Digital Musculoskeletal care platform, partnered with XTRA, the leading 3D AI-powered motion-tracking API provider to enhance their virtual care programs. By generating objective movement data and monitoring adherence to treatment protocols, Upswing Health aims to improve patients' clinical outcomes. Founded by a team of Orthopedic physicians, Upswing Health utilizes AI powered technology and clinical experts to rapidly and virtually evaluate low-and medium-acuity MSK problems. The Upswing care team is made up of Orthopedic Surgeons, Primary Care Sports Medicine Physicians and Certified Athletic Trainers who work together to assess, treat and triage muscle and joint injuries. The partnership with XTRA aims to enhance the remote patient experience and empower clinicians with actionable data to improve care delivery.
• A new health care sector collaboration in Denmark will evaluate the feasibility of recycling used blood collection tubes to reduce medical waste as part of the participants' sustainability goals and Denmark's Climate Action Strategy. The pilot program is a collaboration among BD, Odense University Hospital, the Health Innovation Centre of Southern Denmark, Danish Technological Institute, and GMAF Circular Medico/EcoFitt that will occur at the Odense University Hospital in Odense, Denmark. The initiative models a circular economy, which reduces material use, redesigns materials, products and services to be less resource intensive, and recaptures waste as a resource to manufacture new materials and products. The collaboration is part of a broader effort to further progress toward Denmark's Climate Action Strategy, which aims to reduce the country's greenhouse gas emissions by 70 percent in 2030 compared to 1990 levels.
• The University of Southern Indiana Geriatrics Workforce Enhancement Program launched a new telehealth initiative to improve older adults’ access to medical care. Vanderburgh County residents will be able to participate in telehealth appointments with Deaconess Clinic medical providers at four Evansville Vanderburgh Public Library locations. Telehealth visits virtually connect patients to healthcare providers with appointments ranging from simple phone calls to real-time face-to-face conversations with video via phones, tablets or computers. EVPL staff will help set up any necessary technology for the appointment which may include laptops, headphones and speakers.
• PTP, a cloud consultancy firm specializing in the life sciences industry, announced its partnership with TetraScience, the Scientific Data Cloud company and a pioneer in supporting customers in harmonizing scientific data. This collaboration aims to accelerate and improve the drug discovery and development process, optimize data-driven decision-making, and ultimately improve patient outcomes.
• ProPharma Group, a Research Consulting Organization and a portfolio company of Odyssey Investment Partners, and H1, a healthcare intelligence and analytics provider, announced a strategic partnership to optimize research and development with AI, data-driven insights and analytics. the collaboration combines ProPharma’s global R&D capabilities with H1's robust, real-world data platforms and analytics. With access to real world data covering over 240m patient lives, the partnership with H1 is a critical enabler of ProPharma’s newly introduced RCO model to provide drug and device innovators valuable insights throughout the entire product lifecycle.
• RLDatix, a provider of technology solutions enabling healthcare operations, announced a formal partnership with Nashville General Hospital (NGH), a leading public safety-net hospital serving patients in Nashville, Tenn. RLDatix will implement its entire suite of solutions across the governance, risk, compliance, and workforce management portfolio. By integrating RLDatix solutions, NGH will streamline and generate operational efficiencies, increasing its focus on proactively identifying and addressing risks to patient safety and quality outcomes.
• MediXall Group, a healthcare solutions provider, announced that Thin Blue Line Benefits Association selected MediXall's wholly owned subsidiary, Health Karma, to provide virtual health benefits for its Signature Plan members. As part of this partnership, Health Karma Virtual Urgent Care, Virtual Pet Care, and Virtual Behavioral Health services are included for Thin Blue Line Benefits Signature Plan members, all available 24/7/365 with a $0 co-pay.
• Direct Diagnostics announced their partnership with Lincoln Memorial University-College of Dental Medicine, an educational institution dedicated to preparing future healthcare professionals for success in their fields. Direct Diagnostics will contribute to the university's commitment to facilitating the growth and development of dental and medical education by providing access to its HR5 test, which tests for the top 5 high-risk oral pathogens. This will allow students to learn about the latest advancements in salivary diagnostics and help prepare them for the future of preventative healthcare.
• WHOOP, a wearable health and fitness coach that provides personalized insights via a wrist band and companion app, partnered with the UCI Mountain Bike World Cup. Live biometric data from athletes wearing the devices will be shared during racing, as well as helping to inform the pre and post-show analysis and commentary teams. It's the first time this data has been used in the UCI Mountain Bike World Cup coverage and will bring an entirely new dimension to the broadcasts of downhill and cross-country, thanks to the insights into athletic performance offered by WHOOP.
• HeyPeers and Mindyra Health announced their partnership to provide Mindyra MindHealth Navigator clients the option to access six free certified peer group support sessions per year. This collaboration offers MindHealth Navigator™ users with access to a vital resource that can bridge the gap between working on their mental health challenges independently and working directly with a therapist, offering best-in-class resources to support the diverse mental health needs of employees, college-age students, and others.
• Team Select Home Care, a home care platform that provides care primarily to protected pediatric patient populations, announced a strategic capital investment from Court Square Capital Partners, a middle market-focused private equity firm. With Court Square’s partnership, Team Select Home Care will be well positioned to continue adding branches in select markets and serving current patients and communities. The existing sponsor, Tenex Capital Management, will continue to own a minority stake in the business.
• Life Biosciences, a biotechnology company advancing innovative cellular rejuvenation technologies to reverse diseases of aging and injury and ultimately restore health for patients, and Forge Biologics, a genetic medicines manufacturing organization, announced a manufacturing partnership to help advance Life Bio’s partial epigenetic reprogramming platform to address aging-related diseases, including its lead program targeting ophthalmic indications.
• OSF HealthCare St. Francis Hospital & Medical Group and Bellin Health announced an exclusive partnership that will expand cardiovascular services in Delta County and the surrounding area. OSF Cardiovascular Care with Bellin Health will open later this summer in the OSF Medical Group - Escanaba. This new cardiology clinic will be located in the OSF Medical Office Building and will expand availability by seeing patients five days a week. In addition, a cardiac catheterization lab is scheduled to open in winter 2024 (tentative date). This new cardiac catheterization lab will be housed in OSF St. Francis Hospital and led by the Bellin Health cardiovascular team. It will provide patients with a continuity of care by increasing access to tests and procedures while reducing the need to travel and long wait periods for appointments.
• Kenya is set to partner with South Korea in the area of vaccines and pharmaceuticals manufacturing, with both countries exchanging technology, health financing, management information systems, and health commodity security. This announcement was made during a meeting held today at Afya House in Nairobi, where Cabinet Secretary for Health, Nakhumicha A. Wafula, hosted the visiting Health and Welfare committee members of Gyeonggido provincial government from South Korea, together with the Baringo County Governor, H.E. Benjamin Cheboi.
• Breakout Ventures, the home for creative bioscience entrepreneurs, announced its selection of eight PhD candidates and Postdocs for its two-year Fellowship Program and an inaugural sponsorship of Nucleate, a student-run, nonprofit organization dedicated to empowering the next generation of biotech leaders by educating today’s academic trainees. Breakout Ventures has also announced its sponsorship of three regional chapters of Nucleate’s Activator Program. The Activator Program aims to guide early-stage founders through a series of workshops and events, culminating in a final pitch event to investors. Breakout Ventures has already invested in two Nucleate companies: EnPlusOne in Boston and Vitra Labs in the Bay Area.
• Meals on Wheels America and Home Instead announced a new partnership designed to raise awareness, funding, and volunteers to address the needs of our aging neighbors and curb this health crisis. To kick off the national partnership, Home Instead is matching all donations to Meals on Wheels America made between May 15 and 19, 2023, donating $2 for every $1 donated, up to a $50,000 match. The company also is committing an additional $90,000 to underwrite an inaugural volunteer award that recognizes the tremendous contributions of the individuals who bring the mission to life. The funding will support the local efforts of three winning volunteers' Meals on Wheels organizations. In addition to national initiatives, many members of the Home Instead franchise network will support local Meals on Wheels programs across America through volunteering and other efforts.
• Neuronic, a multi-national company focused on light therapy technology, and Santa Clara University in Silicon Valley, announced a partnership to develop a research project to study photobiomodulation (PBM) guided by real-time brain activity, which will be led by Dr. Julia A. Scott and Dr. Sally Wood. the research team plans to improve the efficacy of PBM delivery, a non-invasive therapy that uses near-infrared light to pass through the skin and activate molecules that improve blood flow, reduce inflammation, and increase cellular energy.
• Siemens Healthineers announced its entrance into an agreement to distribute Scopio Labs' full-field digital cell morphology technology, which will enable clinical laboratorians to examine patient blood cell samples digitally instead of under a microscope. The Scopio X100 and Scopio X100HT imaging platforms1 will complement the Siemens Healthineers systems— including the Atellica HEMA 570 and Atellica HEMA 580 Analyzers2—to offer labs high-resolution, full-field viewing for peripheral blood specimens and artificial intelligence-based morphological analysis with remote capabilities through the secure hospital network.
• Bliss Biopharmaceutical, a clinical-stage biopharmaceutical company developing differentiated antibody-drug conjugate (ADC) therapeutics, announced a clinical trial collaboration agreement with option for strategic collaboration with Eisai for BB-1701, eribulin-payload based ADC directed against Human Epidermal Growth Factor Receptor 2 (HER2) for the treatment of cancers. This collaboration with Eisai is an important advancement in BlissBio's corporate development plan to further develop BB-1701 globally and help advance BB-1701 toward late stage of development. BB-1701 is currently in Phase I/II studies in the US and China with over one hundred patients dosed in various types of cancers.
• Acorda Therapeutics and Hangzhou Chance Pharmaceuticals announced that they have entered into distribution and supply agreements to provide INBRIJA in China. INBRIJA is indicated in the United States for the intermittent treatment of episodic motor fluctuations (OFF episodes) in adult patients with Parkinson's disease (PD) treated with a levodopa/dopa-decarboxylase inhibitor.
• uMotif, a company delivering clinical trials and real-world studies announced a strategic partnership with advanced biostatistics consultancy Veramed. Together, uMotif and Veramed generate high quality, actionable insights to drive quantifiable improvements in clinical research. Through the partnership with Veramed, sponsors get the unique advantages of the industry’s most advanced data analysis and visualization support on top of uMotif’s market-leading platform for ePRO/eCOA data capture, reporting, and analytics.
• MAX Surgical Specialty Management announced its strategic alliance with Coastal Oral Surgery, joining forces with founding partners Riverside Oral Surgery and Oral Surgery Group to create the ultimate surgeon-led oral and maxillofacial surgical specialty platform. Supported by MedEquity Capital, RF Investment Partners, and Kian Capital, MAX is dedicated to building the premier OMS-only specialty platform, emphasizing surgeon autonomy, independent practice identity, and clinical excellence as fundamental organizational values.
• Ripple Science, a digital clinical trial software company, and Curavit Clinical Research, a decentralized clinical trial platform provider, announced the expansion of their partnership with a new three-year agreement. The extended agreement includes exclusive features that further differentiate Curavit's DCT platform. Under the terms of the agreement, Curavit will have access to Ripple software for additional studies to support its growing DCT platform. Curavit will also become a design partner with the right to appoint a representative to Ripple Science's Product Advisory Board. Additionally, Curavit will have the first option to be a beta site and validation partner in the release process of new features.
• Octarine Bio, a synthetic biology company developing new sustainable bio-based ingredients, and Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, announced a multi-stage partnership focused on compounds in the tryptophan pathway, with the objective of engineering a strain for producing violacein and its derivatives, a naturally occurring bis-indole pigment with potent bioactive properties including anti-microbial, anti-oxidant, and UV protective properties. Although initially focused on violacein, the collaboration has the potential to expand to other tryptophan-derived compounds, each with their own unique applications.
• Thermo Fisher Scientific TMO announced a collaboration with Pfizer to increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients. The collaboration will focus on expanding testing capabilities in more than 30 countries across Latin America, Africa, the Middle East and Asia, where access to affordable advanced genomic testing has been previously limited or unavailable. The joint effort of both companies upholds the prospect of bringing rapid NGS testing to an increased number of decentralized labs near the locations of patients undergoing cancer diagnosis.

M&A

• MultiPlan Corporation, a provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. healthcare industry, acquired Benefits Science, a data and advanced analytics company
• A consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital, and Veritas Capital acquired Syneos Health, a fully integrated biopharmaceutical solutions organization
• ŌURA, the company behind the smart ring that delivers personalized health data, insights, and daily guidance, acquired Proxy, developer of a digital identity signal platform
• BetterUp, an AI-driven coaching platform, acquired personalized sleep coaching platform Crescent
• Henry Schein, a provider of health care products and services to office-based dental and medical practitioners, acquired Regional Health Care Group, a medical products distribution company
• Jackson Healthcare, a family of highly specialized healthcare staffing, search and technology companies, acquired LRS Healthcare, which connects nursing and allied healthcare professionals to facilities
• EvokAI Creative Labs, a MedTech AI-powered company dedicated to the development of transformational and innovative technologies for the healthcare sector, entered into a definitive agreement to acquire Rehaboo Oy, a physical gamification platform based on high-definition motion-sensing technology
• Advent International, a global private equity investor, and Warburg Pincus, a global growth investor, acquired global medtech company Baxter International's BioPharma Solutions

Funding Roundup 

• Optain, an AI company that enables early identification and disease prevention through retinal imaging, launched with $12 million from undisclosed investors
• Lucem Health, a provider of transformational clinical AI technology and solutions, raised $7.7 million
• Amino Health, a digital healthcare guidance company, raised $80 million
• Vitamin-One Formulas, a provider of personalized supplements designed to meet individual health needs, raised an undisclosed amount of funding
• Stella, a provider of comprehensive treatment for post traumatic stress, anxiety, stress, depression, traumatic brain injury, and Long COVID, raised $7 million
• Quro Medical, developer of an affordable and accessible hospital-at-home solution, raised $1.3 million
• GenWorks Health, which supports healthcare professionals in rural areas through distribution of affordable and accessible medical devices and consumables, raised $4 million
• Wellthy, a provider of a care concierge platform, raised $25.5 million 
• Prognos Health, a real-world integrated data marketplace, raised $23 million
• Micron Biomedical, a life science company developing dissolvable microarray-based products, raised $3 million
• Ascend Gene & Cell Therapies, a Contract Development & Manufacturing Organization innovating manufacturing processes for gene therapy technologies, raised $117.5 million

(Image source: thousandeyes.com)